CLEMENTI, NICOLA
 Distribuzione geografica
Continente #
EU - Europa 3.594
AS - Asia 2.847
NA - Nord America 2.704
SA - Sud America 695
AF - Africa 79
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.931
Nazione #
US - Stati Uniti d'America 2.558
RU - Federazione Russa 2.062
SG - Singapore 976
CN - Cina 916
BR - Brasile 566
IT - Italia 449
SE - Svezia 378
HK - Hong Kong 338
VN - Vietnam 297
DE - Germania 184
FR - Francia 147
GB - Regno Unito 91
FI - Finlandia 83
CA - Canada 78
IN - India 75
AR - Argentina 52
MX - Messico 49
JP - Giappone 42
PL - Polonia 42
BD - Bangladesh 38
AT - Austria 34
NL - Olanda 32
ZA - Sudafrica 32
TR - Turchia 28
ES - Italia 26
EC - Ecuador 25
IQ - Iraq 24
IE - Irlanda 19
SA - Arabia Saudita 17
ID - Indonesia 15
CO - Colombia 13
PK - Pakistan 12
UZ - Uzbekistan 12
PH - Filippine 11
CL - Cile 10
EG - Egitto 10
LT - Lituania 10
MA - Marocco 10
AE - Emirati Arabi Uniti 8
PY - Paraguay 8
AU - Australia 7
JO - Giordania 7
UY - Uruguay 7
UA - Ucraina 6
VE - Venezuela 6
KE - Kenya 5
PE - Perù 5
RS - Serbia 5
BE - Belgio 4
CH - Svizzera 4
DZ - Algeria 4
KZ - Kazakistan 4
RO - Romania 4
TN - Tunisia 4
CM - Camerun 3
CR - Costa Rica 3
IR - Iran 3
JM - Giamaica 3
MY - Malesia 3
NI - Nicaragua 3
NP - Nepal 3
PA - Panama 3
A1 - Anonimo 2
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EU - Europa 2
GA - Gabon 2
KR - Corea 2
MU - Mauritius 2
PS - Palestinian Territory 2
PT - Portogallo 2
SN - Senegal 2
TH - Thailandia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GD - Grenada 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
MD - Moldavia 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
QA - Qatar 1
Totale 9.927
Città #
Dallas 528
Singapore 492
Moscow 439
Ashburn 423
Hong Kong 335
San Jose 287
Milan 197
Shanghai 190
Beijing 170
New York 140
Hefei 117
Ho Chi Minh City 115
Lauterbourg 99
Los Angeles 86
Princeton 81
Lawrence 78
São Paulo 66
Munich 60
Hanoi 58
Helsinki 48
Orem 39
Nuremberg 36
Rome 36
Warsaw 36
Santa Clara 35
Tokyo 35
Chennai 32
Stockholm 31
Montreal 29
London 26
Denver 25
Brescia 24
Council Bluffs 23
Boardman 22
Falkenstein 22
Brooklyn 21
Johannesburg 21
Atlanta 20
Frankfurt am Main 20
Guangzhou 19
Haiphong 19
Poplar 19
Dublin 18
Mexico City 18
Turku 18
Amsterdam 17
The Dalles 17
Turin 17
Cesano Boscone 16
Lappeenranta 16
Toronto 16
Boston 15
Seattle 15
Shenzhen 15
Vienna 15
Houston 14
Rio de Janeiro 14
Belo Horizonte 13
Chicago 12
Washington 12
Bologna 11
Columbus 11
San Francisco 11
Tashkent 11
Ankara 10
Biên Hòa 10
Tianjin 10
Campinas 9
Hangzhou 9
Manchester 9
Mumbai 9
Porto Alegre 9
Querétaro 9
Brasília 8
Curitiba 8
Salvador 8
Baghdad 7
Barnet 7
Duhok 7
New Delhi 7
Phoenix 7
Pune 7
Amman 6
Assago 6
Cape Town 6
Catania 6
City of London 6
Florianópolis 6
Giza 6
Guarulhos 6
Jeddah 6
Naples 6
Riyadh 6
Verona 6
Bauru 5
Boca 5
Bogotá 5
Calgary 5
Can Tho 5
Caxias do Sul 5
Totale 5.173
Nome #
Evaluation of respiratory virus transmissibility and resilience from fomites: the case of 11 SARS-CoV-2 clinical isolates 178
Beauveria bassiana Keratitis: A Case Series and Review of Literature 161
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 160
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 139
Alternative methods of vaccine delivery: An overview of edible and intradermal vaccines 132
A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination 131
Answer to Photo Quiz: Scolecobasidium sp 131
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 128
The interferon landscape along the respiratory tract impacts the severity of COVID-19 128
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 128
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 127
A Biologically-validated HCV E1E2 Heterodimer Structural Model 127
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 126
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 124
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 122
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 120
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 120
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 120
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 118
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 117
ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota 116
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 115
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 114
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 114
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 111
Cerebral thrombus analysis as a useful diagnostic tool for infective endocarditis in ischemic stroke patients 107
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 107
A new case of Echovirus 11 neonatal fulminant hepatitis involving male twins in a Northern Italy Tertiary University Hospital: Insight on a possible immunological clue 106
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 103
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 102
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules 101
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 101
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 101
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital 101
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 100
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 98
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 98
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 97
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 97
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 97
Clinico-Virological Outcomes and Mutational Profile of SARS-CoV-2 in Adults Treated with Ribavirin Aerosol for COVID-19 Pneumonia 96
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 96
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 96
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 95
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review 95
Rectal Lymphogranuloma venereum among Men who Have Sex with Men: 7 versus 21 Days Doxycycline Effectiveness 94
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 94
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 93
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 92
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 90
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 88
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy 87
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 87
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 86
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 86
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 85
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 84
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition 83
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 82
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 81
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 81
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches 80
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 80
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 80
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity 80
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 79
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 79
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 78
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 78
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 77
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes 76
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 76
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 76
Dual-Domain Reporter Approach for Multiplex Identification of Major SARS-CoV-2 Variants of Concern in a Microarray-Based Assay 75
Inhibiting immunoregulatory amidase NAAA blocks ZIKV maturation in Human Neural Stem Cells 74
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 74
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 74
HCV E2 core structures and mAbs: something is still missing 72
Role and potential therapeutic use of antibodies against herpetic infections 70
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 70
A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders – Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model 69
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 69
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 68
Viral Respiratory Pathogens and Lung Injury 68
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) 67
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 66
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19 65
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? 64
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 64
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 63
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 60
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening 59
Type III interferons disrupt the lung epithelial barrier upon viral recognition 59
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room 59
Comparative Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time Of Flight (MALDI-TOF) Mass Spectrometry Systems for Identification of Yeasts of Medical Importance 58
Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection 58
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 57
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 56
Evaluation of a synergistic interactions of anti-E2/HCV monoclonal antibodies 55
Molecular Cloning of a Human Monoclonal Antibody neutralizing a broad range of H1 subtype influenza virus including swine-origin influenza virus (S-OIV) 54
Totale 9.280
Categoria #
all - tutte 51.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.662


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022115 3 7 13 18 12 7 12 6 3 10 6 18
2022/2023643 191 151 74 8 7 82 43 45 24 2 11 5
2023/2024550 17 31 78 72 45 120 23 48 6 19 19 72
2024/20251.955 178 42 48 77 92 176 320 274 263 147 169 169
2025/20266.835 523 523 660 909 628 231 586 515 1.834 323 103 0
Totale 10.228